Alex Maxwell is Vice President of Business Development, CDMO at Ardena. With extensive experience working with biotech and biopharma clients across the full drug development lifecycle, in both operational and business roles, she knows no two molecules share the same path.
For Alex, better patient outcomes and lasting commercial success starts with strong science, the right people, and a shared stake in the result.
Alex holds an MBA from the University of Florida and degrees in Biomedical and Chemical Engineering from the University of South Florida.